Advanced oxidation protein products play critical roles in liver diseases

There is a complex oxidant and antioxidant system that maintains the redox homoeostasis in the liver. While suffering from exogenous or endogenous risk factors, the balance between oxidants and antioxidants is disturbed and excessive reactive oxygen species are generated, resulting in oxidative stress. Oxidative stress is prevalent in various liver diseases and is thought to be involved in their pathophysiology. Advanced oxidation protein products are generated under conditions of oxidative damage and are newly described protein markers of oxidative stress. Previous studies have underscored the universal pathogenic roles of oxidation protein products in various diseases. However, investigations into how these products participate in the development of liver diseases have been superficial and insufficient. In this review, we highlight the current understanding of the roles of advanced oxidation protein products in liver disease pathogenesis and the underlying mechanisms. Moreover, we summarize the current studies on advanced oxidation protein products in infectious and noninfectious, acute and chronic liver diseases. Different strategies for targeting these advanced oxidation protein products and future perspectives, which may pave the way for developing new therapeutic strategies, will also be discussed here.

[1]  K. Hino,et al.  Mitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection. , 2019, Free radical biology & medicine.

[2]  S. Sood,et al.  Toxic effects of imidacloprid combined with arsenic: Oxidative stress in rat liver , 2018, Toxicology and industrial health.

[3]  B. Lyoussi,et al.  Antioxidant Activity and Protective Effect of Carob Honey in CCl4-induced Kidney and Liver Injury. , 2018, Archives of medical research.

[4]  S. Doǧru-Abbasoǧlu,et al.  The effect of resveratrol on glycation and oxidation products in plasma and liver of chronic methylglyoxal-treated rats , 2018, Pharmacological reports : PR.

[5]  Joseph L Evans,et al.  Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches , 2018, Redox biology.

[6]  M. Nasri,et al.  Modulatory effects of quercetin on liver histopathological, biochemical, hematological, oxidative stress and DNA alterations in rats exposed to graded doses of score 250 , 2018, Toxicology mechanisms and methods.

[7]  Ľ. Tóthová,et al.  Oxidative Stress and Antioxidants in the Diagnosis and Therapy of Periodontitis , 2017, Front. Physiol..

[8]  Qifan Zhang,et al.  Advanced oxidation protein products induce S-phase arrest of hepatocytes via the ROS-dependent, β-catenin-CDK2-mediated pathway , 2017, Redox biology.

[9]  G. Kocic,et al.  Relationship between Oxidative Stress, Inflammation and Dyslipidemia with Fatty Liver Index in Patients with Type 2 Diabetes Mellitus , 2017, Experimental and Clinical Endocrinology & Diabetes.

[10]  M. Baldissera,et al.  Melaleuca alternifolia essential oil nanoparticles ameliorate the hepatic antioxidant/oxidant status of silver catfish experimentally infected with Pseudomonas aeruginosa. , 2017, Microbial pathogenesis.

[11]  Jing Tang,et al.  Advanced Oxidation Protein Products Induce Epithelial-Mesenchymal Transition of Intestinal Epithelial Cells via a PKC δ-Mediated, Redox-Dependent Signaling Pathway. , 2017, Antioxidants & redox signaling.

[12]  Zeghal Najiba,et al.  Oxidative stress and histopathological changes induced by methylthiophanate, a systemic fungicide, in blood, liver and kidney of adult rats. , 2017, African health sciences.

[13]  Qifan Zhang,et al.  Advanced oxidation protein products induce hepatocyte epithelial–mesenchymal transition via a ROS‐dependent, TGF‐β/Smad signaling pathway , 2017, Cell biology international.

[14]  N. Zeghal,et al.  Effects of acrylamide graded doses on metallothioneins I and II induction and DNA fragmentation: Bochemical and histomorphological changes in the liver of adult rats , 2017, Toxicology and industrial health.

[15]  M. Maes,et al.  Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis , 2016, Molecular Neurobiology.

[16]  S. Doǧru-Abbasoǧlu,et al.  The effect of carnosine on methylglyoxal-induced oxidative stress in rats , 2017, Archives of physiology and biochemistry.

[17]  Ning Wang,et al.  Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases , 2016, Oxidative medicine and cellular longevity.

[18]  J. Kanwar,et al.  Redox Control of Antioxidant and Antihepatotoxic Activities of Cassia surattensis Seed Extract against Paracetamol Intoxication in Mice: In Vitro and In Vivo Studies of Herbal Green Antioxidant , 2016, Oxidative medicine and cellular longevity.

[19]  Zhao‐ming Zhong,et al.  Advanced oxidation protein products sensitized the transient receptor potential vanilloid 1 via NADPH oxidase 1 and 4 to cause mechanical hyperalgesia , 2016, Redox biology.

[20]  T. Nishiya,et al.  Promising toxicological biomarkers for the diagnosis of liver injury types: Bile acid metabolic profiles and oxidative stress marker as screening tools in drug development. , 2016, Chemico-biological interactions.

[21]  T. Carbonell,et al.  Hypothermia can reverse hepatic oxidative stress damage induced by hypoxia in rats , 2016, Journal of Physiology and Biochemistry.

[22]  C. Panis,et al.  Profile of oxidative stress markers is dependent on vitamin D levels in patients with chronic hepatitis C. , 2016, Nutrition.

[23]  N. Zeghal,et al.  The protective effect of propylthiouracil against hepatotoxicity induced by chromium in adult mice , 2016, Toxicology and industrial health.

[24]  Y. Liu,et al.  Biomarkers of oxidation stress, inflammation, necrosis and apoptosis are associated with hepatitis B-related acute-on-chronic liver failure. , 2016, Clinics and research in hepatology and gastroenterology.

[25]  J. Camacho,et al.  Ion Channels and Oxidative Stress as a Potential Link for the Diagnosis or Treatment of Liver Diseases , 2016, Oxidative medicine and cellular longevity.

[26]  Ľ. Tóthová,et al.  Variability of salivary markers of oxidative stress and antioxidant status in young healthy individuals , 2016, Redox report : communications in free radical research.

[27]  Luízi P. Campos,et al.  Oxidative stress associated with pathological lesions in the liver of rats experimentally infected by Fasciola hepatica. , 2015, Experimental parasitology.

[28]  E. Murawska-Ciałowicz,et al.  Increased Circulating Advanced Oxidation Protein Products and High-Sensitive Troponin T in Cirrhotic Patients with Chronic Hepatitis C: A Preliminary Report , 2015, BioMed research international.

[29]  Ning Wang,et al.  The Role of Oxidative Stress and Antioxidants in Liver Diseases , 2015, International journal of molecular sciences.

[30]  M. Özsoy,et al.  Serum levels of nitrate, nitrite and advanced oxidation protein products (AOPP) in patients with nonalcoholic fatty liver disease. , 2015, Acta gastro-enterologica Belgica.

[31]  Hemayet Hossain,et al.  Supplementation of Citrus maxima Peel Powder Prevented Oxidative Stress, Fibrosis, and Hepatic Damage in Carbon Tetrachloride (CCl4) Treated Rats , 2015, Evidence-based complementary and alternative medicine : eCAM.

[32]  A. Gonçalves,et al.  Oxidative stress and mitochondrial dysfunction play a role in myelodysplastic syndrome development, diagnosis, and prognosis: A pilot study , 2015, Free radical research.

[33]  M. Başkol,et al.  Advanced oxidation protein products, total thiol levels and total oxidant/antioxidant status in patients with nash. , 2015, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[34]  A. Allegra,et al.  Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura , 2015, European journal of haematology.

[35]  N. Seyhan,et al.  The effects of N-acetylcysteine and epigallocatechin-3-gallate on liver tissue protein oxidation and antioxidant enzyme levels after the exposure to radiofrequency radiation , 2015, International journal of radiation biology.

[36]  Yang Bu,et al.  Advanced Oxidation Protein Products Induce Hypertrophy and Epithelial-To-Mesenchymal Transition in Human Proximal Tubular Cells through Induction of Endoplasmic Reticulum Stress , 2015, Cellular Physiology and Biochemistry.

[37]  J. Everhart,et al.  Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey , 2015, Alimentary pharmacology & therapeutics.

[38]  F. Hou,et al.  AOPPs and the progression of kidney disease , 2014, Kidney international supplements.

[39]  P. Xiu,et al.  Vitamin A Supplementation Alleviates Extrahepatic Cholestasis Liver Injury through Nrf2 Activation , 2014, Oxidative medicine and cellular longevity.

[40]  G. Valacchi,et al.  Redox Imbalance and Morphological Changes in Skin Fibroblasts in Typical Rett Syndrome , 2014, Oxidative medicine and cellular longevity.

[41]  G. Yılmaz,et al.  The relationship between advanced oxidation protein products (AOPP) and biochemical and histopathological findings in patients with nonalcoholic steatohepatitis , 2014, Journal of digestive diseases.

[42]  M. Pazgan-Simon,et al.  Ischemia-modified albumin (IMA) is increased in patients with chronic hepatitis C infection and related to markers of oxidative stress and inflammation. , 2012, Acta biochimica Polonica.

[43]  Youhua Liu,et al.  The receptor of advanced glycation end products plays a central role in advanced oxidation protein products-induced podocyte apoptosis. , 2012, Kidney international.

[44]  O. Mir,et al.  Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species Production In Vitro and In Vivo , 2012, Molecular Cancer Therapeutics.

[45]  P. Olczyk,et al.  Age- and gender-related alteration in plasma advanced oxidation protein products (AOPP) and glycosaminoglycan (GAG) concentrations in physiological ageing , 2012, Clinical chemistry and laboratory medicine.

[46]  Y. Li,et al.  Monitoring oxidative stress in acute‐on‐chronic liver failure by advanced oxidation protein products , 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

[47]  G. Musso,et al.  Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity , 2011, Annals of medicine.

[48]  C. Panis,et al.  Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erythematosus , 2011, Lupus.

[49]  A. Sugiyama,et al.  Expressions of protein oxidation markers, dityrosine and advanced oxidation protein products in acetaminophen-induced liver injury in rats. , 2011, The Journal of veterinary medical science.

[50]  A. Bilgihan,et al.  Serum levels of advanced oxidation protein products, malonyldialdehyde, and total radical trapping antioxidant parameter in patients with chronic hepatitis C. , 2011, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[51]  H. Kim,et al.  Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[52]  N. Lundbom,et al.  Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. , 2009, Gastroenterology.

[53]  H. Scharnagl,et al.  Plasma-Advanced Oxidation Protein Products Are Potent High-Density Lipoprotein Receptor Antagonists In Vivo , 2009, Circulation research.

[54]  P. Stenvinkel,et al.  Modification of the oxidative stress biomarker AOPP assay: application in uremic samples. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[55]  C. Goulvestre,et al.  Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis , 2007, Annals of the rheumatic diseases.

[56]  Ping-yan Chen,et al.  Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. , 2007, Journal of the American Society of Nephrology : JASN.

[57]  Anna Castiglione,et al.  The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population , 2006, BMC gastroenterology.

[58]  David E. J. Jones,et al.  Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease , 2004, Hepatology.

[59]  B. Descamps-Latscha,et al.  AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. , 2003, Kidney international.

[60]  P. Jungers,et al.  Advanced oxidation protein products as a novel marker of oxidative stress in uremia. , 1996, Kidney international.

[61]  S. Sarin,et al.  Modification Patterns of Urinary Albumin Correlates With Serum Albumin and Outcome in Severe Alcoholic Hepatitis , 2019, Journal of clinical gastroenterology.

[62]  K. Kısmet,et al.  Melatonin: a hepatoprotective agent against radioiodine toxicity in rats. , 2017, Bratislavske lekarske listy.

[63]  M. E. El Batsh,et al.  Protective Effects of Combined Selenium and Punica granatum Treatment on Some Inflammatory and Oxidative Stress Markers in Arsenic-Induced Hepatotoxicity in Rats , 2015, Biological Trace Element Research.

[64]  D. Giustarini,et al.  A central role for intermolecular dityrosine cross-linking of fibrinogen in high molecular weight advanced oxidation protein product (AOPP) formation. , 2015, Biochimica et biophysica acta.

[65]  R. A. Vaucher,et al.  In Vitro Oxidation of Fibrinogen Promotes Functional Alterations and Formation of Advanced Oxidation Protein Products, an Inflammation Mediator , 2014, Inflammation.

[66]  F. Hou,et al.  Advanced oxidation protein products activate intrarenal renin-angiotensin system via a CD36-mediated, redox-dependent pathway. , 2013, Antioxidants & redox signaling.

[67]  K. Simon,et al.  Elevated Advanced Oxidation Protein Products Levels in Patients with Liver Cirrhosis , 2022 .

[68]  M. Otagiri,et al.  The structural and pharmacokinetic properties of oxidized human serum albumin, advanced oxidation protein products (AOPP). , 2006, Drug metabolism and pharmacokinetics.